Collegium Pharmaceutical, Inc. (COLL)
27.39
+0.28
(+1.02%)
USD |
NASDAQ |
Aug 24, 16:00
27.39
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Market Cap : 890.03M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 881.03M |
| August 20, 2026 | 895.00M |
| August 19, 2026 | 934.00M |
| August 18, 2026 | 926.20M |
| August 17, 2026 | 912.23M |
| August 14, 2026 | 917.43M |
| August 13, 2026 | 914.83M |
| August 12, 2026 | 835.21M |
| August 11, 2026 | 844.31M |
| August 10, 2026 | 883.95M |
| August 07, 2026 | 957.72M |
| August 06, 2026 | 946.03M |
| August 05, 2026 | 1.161B |
| August 04, 2026 | 1.161B |
| August 03, 2026 | 1.153B |
| July 31, 2026 | 1.147B |
| July 30, 2026 | 1.166B |
| July 29, 2026 | 1.176B |
| July 28, 2026 | 1.163B |
| July 27, 2026 | 1.151B |
| July 24, 2026 | 1.141B |
| July 23, 2026 | 1.153B |
| July 22, 2026 | 1.125B |
| July 21, 2026 | 1.162B |
| July 20, 2026 | 1.152B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.169B |
| July 16, 2026 | 1.175B |
| July 15, 2026 | 1.190B |
| July 14, 2026 | 1.135B |
| July 13, 2026 | 1.128B |
| July 10, 2026 | 1.142B |
| July 09, 2026 | 1.160B |
| July 08, 2026 | 1.161B |
| July 07, 2026 | 1.181B |
| July 06, 2026 | 1.214B |
| July 02, 2026 | 1.200B |
| July 01, 2026 | 1.162B |
| June 30, 2026 | 1.173B |
| June 29, 2026 | 1.166B |
| June 26, 2026 | 1.186B |
| June 25, 2026 | 1.129B |
| June 24, 2026 | 1.153B |
| June 23, 2026 | 1.122B |
| June 22, 2026 | 1.084B |
| June 18, 2026 | 1.087B |
| June 17, 2026 | 1.091B |
| June 16, 2026 | 1.123B |
| June 15, 2026 | 1.108B |
| June 12, 2026 | 1.123B |
| June 11, 2026 | 1.113B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.528B |
| Zevra Therapeutics, Inc. | 691.93M |
| Supernus Pharmaceuticals, Inc. | 2.624B |
| Indivior Pharmaceuticals, Inc. | 4.269B |
| Crinetics Pharmaceuticals, Inc. | 8.971B |
Market Cap Related Metrics
| PE Ratio | 22.19 |
| PS Ratio | 1.288 |
| PEG Ratio | 1.159 |
| Price to Book Value | 2.853 |
| Price to Free Cash Flow | 3.171 |
| Price | 27.39 |
| Earnings Yield | 4.51% |
| PEGY Ratio | 1.159 |
| Operating PE Ratio | 6.402 |
| Normalized PE Ratio | 16.98 |